Injectable Drug Delivery Devices Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Injectors, Pen), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology, Obesity, Diabetes Mellitus), By End Use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Product
                        1.2.2. Drug Type
                        1.2.3. Therapeutic Use
                        1.2.4. End Use
                    1.3. Estimation and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Materials & Third-Party Perspectives
                        1.5.4. Primary Research
                    1.6. Information or Data Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Validation
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                            1.8.1.1. Research Scope and Assumptions
                            1.8.1.2. Research Methodology and Assumptions
                        1.8.2. Volume Price Analysis
                        1.8.3. CDMO injectable drug delivery devices Market
                    1.9. List of Secondary Sources
                    1.10. List of Abbreviations
                    1.11. Objectives
                        1.11.1. Objective 1
                        1.11.2. Objective 2
                        1.11.3. Objective 3
Chapter 2. Executive Summary
                    2.1. Market Snapshot (Regional)
                    2.2. Segment Snapshot (Product)
                    2.3. Segment Snapshot (Therapeutic Use)
                    2.4. Segment Snapshot (End-use)
                    2.5. Market Concentration
                    2.6. Injectable Drug Delivery Devices Market Variables and Trends Market Lineage Outlook
                    2.7. Market Dynamics
                        2.7.1. Market Driver Impact Analysis
                        2.7.2. Market Restraint Analysis
                        2.7.3. Market Opportunity Analysis
                    2.8. Industry Analysis Tools
                        2.8.1. Porter’s Five Forces Analysis
                        2.8.2. Macroeconomic Analysis
                    2.9. List of CDMO Manufacturers and Supplied Injectable Drug Delivery Devices to Companies
                        2.9.1. List of In-House Manufacturers of Injectable Drug Delivery Devices
                        2.9.2. Qualitative Insights on Potential Impact of New Injectables or Oral Drugs and Development of Multi-Dose Devices, by Region
                        2.9.3. North America
                        2.9.4. Europe
                        2.9.5. Asia
                    2.10. Global CDMO Injectable Drug Delivery Devices Market, by Product, 2021 - 2033 (value in USD Billion and Volume in Units Sold)
                        2.10.1. Global CDMO Injectable Drug Delivery Devices Market, by Product, 2021 - 2033 (USD Billion)
                        2.10.2. Global CDMO Injectable Drug Delivery Devices Market, by Product, 2021 - 2033 (Units)
Chapter 3. Injectable Drug Delivery Devices Market: Product Analysis
                    3.1. Product Movement Analysis & Market Share, 2025 & 2033
                    3.2. Injectable Drug Delivery Devices Market Estimates & Forecast, by Product (USD Billion, Units)
                    3.3. Market Size & Forecasts and Trend Analysis, 2021 - 2033
                        3.3.1. Injectors
                            3.3.1.1. Injectors Market, 2021 - 2033 (USD Billion, Units)
                            3.3.1.2. GLP-1 Agonists
                                3.3.1.2.1. GLP-1 Agonists Market, 2021 - 2033 (USD Billion, Units)
                            3.3.1.3. Hormone Therapies
                                3.3.1.3.1. Hormone Therapies Market, 2021 - 2033 (USD Billion, Units)
                            3.3.1.4. Biologics
                                3.3.1.4.1. Biologics Market, 2021 - 2033 (USD Billion, Units)
                            3.3.1.5. Others
                                3.3.1.5.1. Others Market, 2021 - 2033 (USD Billion, Units)
                        3.3.2. Pens
                            3.3.2.1. Pens Market, 2021 - 2033 (USD Billion, Units)
                            3.3.2.2. GLP-1 Agonists
                                3.3.2.2.1. GLP-1 Agonists Market, 2021 - 2033 (USD Billion, Units)
                            3.3.2.3. Insulin
                                3.3.2.3.1. Insulin Market, 2021 - 2033 (USD Billion, Units)
                            3.3.2.4. Hormone Therapies
                                3.3.2.4.1. Hormone Therapies Market, 2021 - 2033 (USD Billion, Units)
                            3.3.2.5. Others
                                3.3.2.5.1. Other Market Estimates & Forecasts, 2021 - 2033 (USD Billion, Units)
Chapter 4. Injectable Drug Delivery Devices Market: Therapeutic Use Estimates & Trend Analysis
                    4.1. Therapeutic Area Movement Analysis & Market Share, 2025 & 2033
                    4.2. Injectable Drug Delivery Devices Market Estimates & Forecast, by Therapeutic Use (USD Billion, Units)
                    4.3. Market Size & Forecasts and Trend Analysis, 2021 - 2033
                        4.3.1. Autoimmune Disorders
                            4.3.1.1. Autoimmune Disorders Market, 2021 - 2033 (USD Billion, Units)
                        4.3.2. Hormonal Disorders
                            4.3.2.1. Hormonal Disorders Market, 2021 - 2033 (USD Billion, Units)
                        4.3.3. Oncology
                            4.3.3.1. Oncology Market, 2021 - 2033 (USD Billion, Units)
                        4.3.4. Obesity
                            4.3.4.1. Obesity Market, 2021 - 2033 (USD Billion, Units)
                        4.3.5. Diabetes Mellitus
                            4.3.5.1. Diabetes Mellitus Market, 2021 - 2033 (USD Billion, Units)
                        4.3.6. Others
                            4.3.6.1. Others Market, 2021 - 2033 (USD Billion, Units)
Chapter 5. Injectable Drug Delivery Devices Market: End Use Analysis
                    5.1. End Use Movement Analysis & Market Share, 2025 & 2033
                    5.2. Injectable Drug Delivery Devices Market Estimates & Forecast, by End Use (USD Billion, Units)
                    5.3. Market Size & Forecasts and Trend Analysis, 2021 - 2033
                        5.3.1. Hospitals
                            5.3.1.1. Hospitals Market, 2021 - 2033 (USD Billion, Units)
                        5.3.2. Homecare Settings
                            5.3.2.1. Homecare Settings Market, 2021 - 2033 (USD Billion, Units)
                        5.3.3. Others
                            5.3.3.1. Others Market, 2021 - 2033 (USD Billion, Units)
Chapter 6. Injectable Drug Delivery Devices Market: Regional Estimates & Trend Analysis
                    6.1. Injectable Drug Delivery Devices Market: Regional Outlook
                    6.2. North America
                        6.2.1. North America Injectable Drug Delivery Devices Market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
                        6.2.2. U.S.
                            6.2.2.1. Competitive Scenario
                            6.2.2.2. Regulatory framework
                            6.2.2.3. Reimbursement Structure
                            6.2.2.4. U.S. Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.2.3. Canada
                            6.2.3.1. Competitive Scenario
                            6.2.3.2. Regulatory framework
                            6.2.3.3. Reimbursement Structure
                            6.2.3.4. Canada Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.2.4. Mexico
                            6.2.4.1. Competitive Scenario
                            6.2.4.2. Regulatory framework
                            6.2.4.3. Reimbursement Structure
                            6.2.4.4. Mexico Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                    6.3. Europe
                        6.3.1. Europe Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.3.2. UK
                            6.3.2.1. Competitive Scenario
                            6.3.2.2. Regulatory framework
                            6.3.2.3. Reimbursement Structure
                            6.3.2.4. UK Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.3.3. Germany
                            6.3.3.1. Competitive Scenario
                            6.3.3.2. Regulatory framework
                            6.3.3.3. Reimbursement Structure
                            6.3.3.4. Germany Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.3.4. France
                            6.3.4.1. Competitive Scenario
                            6.3.4.2. Regulatory framework
                            6.3.4.3. Reimbursement Structure
                            6.3.4.4. France Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.3.5. Italy
                            6.3.5.1. Competitive Scenario
                            6.3.5.2. Regulatory framework
                            6.3.5.3. Reimbursement Structure
                            6.3.5.4. Italy Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.3.6. Spain
                            6.3.6.1. Competitive Scenario
                            6.3.6.2. Regulatory framework
                            6.3.6.3. Reimbursement Structure
                            6.3.6.4. Spain Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.3.7. Norway
                            6.3.7.1. Competitive Scenario
                            6.3.7.2. Regulatory framework
                            6.3.7.3. Reimbursement Structure
                            6.3.7.4. Norway Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.3.8. Sweden
                            6.3.8.1. Competitive Scenario
                            6.3.8.2. Regulatory framework
                            6.3.8.3. Reimbursement Structure
                            6.3.8.4. Sweden Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.3.9. Denmark
                            6.3.9.1. Competitive Scenario
                            6.3.9.2. Regulatory framework
                            6.3.9.3. Reimbursement Structure
                            6.3.9.4. Denmark Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                    6.4. Asia
                        6.4.1. Asia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.4.2. China
                            6.4.2.1. Competitive Scenario
                            6.4.2.2. Regulatory framework
                            6.4.2.3. Reimbursement Structure
                            6.4.2.4. China Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.4.3. Japan
                            6.4.3.1. Competitive Scenario
                            6.4.3.2. Regulatory framework
                            6.4.3.3. Reimbursement Structure
                            6.4.3.4. Japan Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.4.4. India
                            6.4.4.1. Competitive Scenario
                            6.4.4.2. Regulatory framework
                            6.4.4.3. Reimbursement Structure
                            6.4.4.4. India Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.4.5. Thailand
                            6.4.5.1. Competitive Scenario
                            6.4.5.2. Regulatory framework
                            6.4.5.3. Reimbursement Structure
                            6.4.5.4. Thailand Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.4.6. South Korea
                            6.4.6.1. Competitive Scenario
                            6.4.6.2. Regulatory framework
                            6.4.6.3. Reimbursement Structure
                            6.4.6.4. South Korea Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.4.7. Saudi Arabia
                            6.4.7.1. Competitive Scenario
                            6.4.7.2. Regulatory framework
                            6.4.7.3. Reimbursement Structure
                            6.4.7.4. Saudi Arabia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.4.8. UAE
                            6.4.8.1. Competitive Scenario
                            6.4.8.2. Regulatory framework
                            6.4.8.3. Reimbursement Structure
                            6.4.8.4. UAE Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
                        6.4.9. Kuwait
                            6.4.9.1. Competitive Scenario
                            6.4.9.2. Regulatory framework
                            6.4.9.3. Reimbursement Structure
                            6.4.9.4. Kuwait Injectable Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Billion, Units)
Chapter 7. Injectable Drug Delivery Devices Market: Competitive Analysis
                    7.1. Company Categorization
                    7.2. Participant’s Overview
                    7.3. Financial Performance
                    7.4. Product Offerings
                    7.5. Company Market Position Analysis
                    7.6. Company Market Share Analysis, 2025 (%)
                    7.7. Strategy Mapping
                        7.7.1. Product Launches & Approvals
                        7.7.2. Partnerships & Collaborations
                        7.7.3. Mergers & Acquisitions
                        7.7.4. Expansions
                        7.7.5. Others
                    7.8. Company Profiles
                        7.8.1. Novo Nordisk A/S
                            7.8.1.1. Company Overview
                            7.8.1.2. Financial Performance
                            7.8.1.3. Product Benchmarking
                            7.8.1.4. Strategic Initiatives
                        7.8.2. Sanofi
                            7.8.2.1. Company Overview
                            7.8.2.2. Financial Performance
                            7.8.2.3. Product Benchmarking
                            7.8.2.4. Strategic Initiatives
                        7.8.3. Eli Lilly and Company
                            7.8.3.1. Company Overview
                            7.8.3.2. Financial Performance
                            7.8.3.3. Product Benchmarking
                            7.8.3.4. Strategic Initiatives
                        7.8.4. AstraZeneca plc
                            7.8.4.1. Company Overview
                            7.8.4.2. Financial Performance
                            7.8.4.3. Product Benchmarking
                            7.8.4.4. Strategic Initiatives
                        7.8.5. Pfizer, Inc.
                            7.8.5.1. Company Overview
                            7.8.5.2. Financial Performance
                            7.8.5.3. Product Benchmarking
                            7.8.5.4. Strategic Initiatives
                        7.8.6. Merck KGaA
                            7.8.6.1. Company Overview
                            7.8.6.2. Financial Performance
                            7.8.6.3. Product Benchmarking
                            7.8.6.4. Strategic Initiatives
                        7.8.7. Teva Pharmaceuticals
                            7.8.7.1. Company Overview
                            7.8.7.2. Financial Performance
                            7.8.7.3. Product Benchmarking
                            7.8.7.4. Strategic Initiatives
                        7.8.8. Amgen, Inc.
                            7.8.8.1. Company Overview
                            7.8.8.2. Financial Performance
                            7.8.8.3. Product Benchmarking
                            7.8.8.4. Strategic Initiatives
                        7.8.9. Ferring Pharmaceuticals
                            7.8.9.1. Company Overview
                            7.8.9.2. Financial Performance
                            7.8.9.3. Product Benchmarking
                            7.8.9.4. Strategic Initiatives
                        7.8.10. AbbVie, Inc.
                            7.8.10.1. Company Overview
                            7.8.10.2. Financial Performance
                            7.8.10.3. Product Benchmarking
                            7.8.10.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Estimated number of new cancer cases for all cancer types from 2025 to 2030, Incidence, Both sexes, age [0-85+]
Table 3 Estimated global prevalence and mortality of major chronic diseases, 2025
Table 4 Comparison of injectable drug delivery devices and conventional therapies: cost and long-term value
Table 5 Device preferences for top biologic classes
Table 6 Regional comparison of injectable drug delivery ecosystem maturity in North America
Table 7 Europe diabetes burden and prevalence trends (2000, 2011, 2024, and 2030 estimates)
Table 8 Major companies offering autoinjectors
Table 9 Key companies and their prefilled/smart pen product offerings
Table 10 Global injectable drug delivery devices market revenue estimates and forecast, by product, 2021 - 2033 (USD Billion, Units)
Table 11 Global injectable drug delivery devices market revenue estimates and forecast, by drug type, 2021 - 2033 (USD Billion, Units)
Table 12 Global injectors market, by drug type, 2021 - 2033 (USD Billion, Units)
Table 13 Global pen market, by drug type, 2021 - 2033 (USD Billion, Units)
Table 14 Key GLP-1 agonist pen products
Table 15 Global injectable drug delivery devices market revenue estimates and forecast, by therapeutic use, 2021 - 2033 (USD Billion, Units)
Table 16 Global ranking of countries by obesity prevalence (%)
Table 17 Global injectable drug delivery devices market revenue estimates and forecast, by end use, 2021 - 2033 (USD Billion, Units)
Table 18 Canada regulatory procedure for medical devices
Table 19 Cancer statistics and rankings for France, 2022

List of Figures

Fig. 1 Injectable drug delivery devices market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based size & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Injectable drug delivery devices market revenue
Fig. 9 Volume price analysis
Fig. 10 CDMO injectable drug delivery devices market revenue
Fig. 11 Market snapshot (regional)
Fig. 12 Segment snapshot (product)
Fig. 13 Segment snapshot (drug type)
Fig. 14 Segment snapshot (therapeutic use)
Fig. 15 Segment snapshot (end-use)
Fig. 16 Market concentration
Fig. 17 Injectable drug delivery devices market dynamics
Fig. 18 Injectable drug delivery devices market: PORTER’s analysis
Fig. 19 Injectable drug delivery devices market: PESTEL analysis
Fig. 20 Estimated number of cancer cases in Europe, by Country, 2022 Vs 2025 Vs 2030
Fig. 21 Injectable drug delivery devices market, by product: Key takeaways
Fig. 22 Injectable drug delivery devices market, by product: Market share, 2025 & 2033
Fig. 23 Injectors market, 2021 - 2033 (USD Billion, Units)
Fig. 24 Pens market, 2021 - 2033 (USD Billion, Units)
Fig. 25 Injectable drug delivery devices market, by drug type: Key takeaways
Fig. 26 Injectable drug delivery devices market, by drug type: Market share, 2025 & 2033
Fig. 27 GLP-1 agonists market, 2021 - 2033 (USD Billion, Units)
Fig. 28 Hormone therapies market, 2021 - 2033 (USD Billion, Units)
Fig. 29 Biologics market, 2021 - 2033 (USD Billion, Units)
Fig. 30 Others market, 2021 - 2033 (USD Billion, Units)
Fig. 31 GLP-1 agonists market, 2021 - 2033 (USD Billion, Units)
Fig. 32 Insulin market, 2021 - 2033 (USD Billion, Units)
Fig. 33 Hormone therapies market, 2021 - 2033 (USD Billion, Units)
Fig. 34 Others market, 2021 - 2033 (USD Billion, Units)
Fig. 35 Injectable drug delivery devices market, by therapeutic use: Key takeaways
Fig. 36 Injectable drug delivery devices market, by therapeutic use: Market share, 2025 & 2033
Fig. 37 Autoimmune disorders market, 2021 - 2033 (USD Billion, Units)
Fig. 38 Hormonal disorders market, 2021 - 2033 (USD Billion, Units)
Fig. 39 Oncology market, 2021 - 2033 (USD Billion, Units)
Fig. 40 Obesity market, 2021 - 2033 (USD Billion, Units)
Fig. 41 Diabetes mellitus market, 2021 - 2033 (USD Billion, Units)
Fig. 42 Others market, 2021 - 2033 (USD Billion, Units)
Fig. 43 Injectable drug delivery devices market, by end use: Key takeaways
Fig. 44 Injectable drug delivery devices market, by end use: Market share, 2025 & 2033
Fig. 45 Hospitals market, 2021 - 2033 (USD Billion, Units)
Fig. 46 Homecare settings market, 2021 - 2033 (USD Billion, Units)
Fig. 47 Others market, 2021 - 2033 (USD Billion, Units)
Fig. 48 Injectable drug delivery devices market revenue, by region, 2025 & 2033 (USD Billion, Units)
Fig. 49 Regional marketplace: Key takeaways
Fig. 50 Regional marketplace: Key takeaways
Fig. 51 North America injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 52 Estimated number of new cancer cases, by State - 2025
Fig. 53 Diagnosed diabetes - total, adults aged 18+ years, age-adjusted percentage (2023)
Fig. 54 Reimbursement procurement process
Fig. 55 U S injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 56 Diabetes mellitus (types combined), excluding gestational diabetes, age-standardized incidence rate, per 100,000, age 1 year old and older, Canada
Fig. 57 Canada injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 58 Mexico injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 59 Europe injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 60 UK injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 61 Germany injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 62 France injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 63 Italy injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 64 Spain injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 65 Sweden injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 66 Norway injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 67 Denmark injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 68 Asia injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 69 China injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 70 Japan injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 71 India injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 72 Thailand injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 73 South Korea pen and injector drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 74 Saudi Arabia injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 75 UAE injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 76 Kuwait injectable drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Billion, Units)
Fig. 77 Key company categorization
Fig. 78 Company market share analysis, 2025
Fig. 79 Strategy mapping